300 related articles for article (PubMed ID: 19095200)
1. Economics and cost of care of stone disease.
Lotan Y
Adv Chronic Kidney Dis; 2009 Jan; 16(1):5-10. PubMed ID: 19095200
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
J Urol; 2013 Mar; 189(3):935-9. PubMed ID: 23017509
[TBL] [Abstract][Full Text] [Related]
5. National health care costs of peripheral arterial disease in the Medicare population.
Hirsch AT; Hartman L; Town RJ; Virnig BA
Vasc Med; 2008 Aug; 13(3):209-15. PubMed ID: 18687757
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
7. Economics of stone management.
Lotan Y; Pearle MS
Urol Clin North Am; 2007 Aug; 34(3):443-53. PubMed ID: 17678993
[TBL] [Abstract][Full Text] [Related]
8. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
9. Update on the medical management of stone disease.
Tracy CR; Pearle MS
Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
11. Renal stone disease in Christchurch, New Zealand. Part 2: a community study on the burden of renal stone disease.
Davidson PJ; Sheerin IG; Frampton C
N Z Med J; 2009 Jun; 122(1297):57-67. PubMed ID: 19649002
[TBL] [Abstract][Full Text] [Related]
12. Urologic diseases in America project: urolithiasis.
Pearle MS; Calhoun EA; Curhan GC;
J Urol; 2005 Mar; 173(3):848-57. PubMed ID: 15711292
[TBL] [Abstract][Full Text] [Related]
13. Prospects for dietary therapy of recurrent nephrolithiasis.
Goldfarb DS
Adv Chronic Kidney Dis; 2009 Jan; 16(1):21-9. PubMed ID: 19095202
[TBL] [Abstract][Full Text] [Related]
14. The economics of stone disease.
Canvasser NE; Alken P; Lipkin M; Nakada SY; Sodha HS; Tepeler A; Lotan Y
World J Urol; 2017 Sep; 35(9):1321-1329. PubMed ID: 28108799
[TBL] [Abstract][Full Text] [Related]
15. Economic Considerations in the Management of Nephrolithiasis.
Roberson D; Sperling C; Shah A; Ziemba J
Curr Urol Rep; 2020 Mar; 21(5):18. PubMed ID: 32236700
[TBL] [Abstract][Full Text] [Related]
16. Metaphylaxis of nephrolithiasis.
Jacobellis U
Urol Int; 2007; 79 Suppl 1():51-5. PubMed ID: 17726353
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and economics of nephrolithiasis.
Ziemba JB; Matlaga BR
Investig Clin Urol; 2017 Sep; 58(5):299-306. PubMed ID: 28868500
[TBL] [Abstract][Full Text] [Related]
18. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
Wallner PE; Konski A
J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
[TBL] [Abstract][Full Text] [Related]
19. Cost of care for new versus recurrent acute coronary syndrome patients.
Shetty S; Halpern R; McCollam PL
J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
[TBL] [Abstract][Full Text] [Related]
20. Nephrolithiasis: evaluation and management.
Brener ZZ; Winchester JF; Salman H; Bergman M
South Med J; 2011 Feb; 104(2):133-9. PubMed ID: 21258231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
